**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 1310-73-2 |Sodium hydroxide | | 215-185-5 |
|----------------|--------------------------------------|----------|-----------|
| 7732-18-5 |Water | | 231-791-2 |
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea.
Inhalation:
May cause respiratory tract irritation.
Chronic:
Not available.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin
and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 1310-73-2:
United Kingdom, WEL - STEL: 2 mg/m3 STEL
United States OSHA: 2 mg/m3 TWA
Belgium - TWA: 2 mg/m3 VLE
France - VME: 2 mg/m3 VME
Germany: 2 mg/m3 TWA (inhalable fraction)
Japan: 2 mg/m3 Ceiling
Malaysia: 2 mg/m3 Ceiling
Spain: 2 mg/m3 VLA-EC
CAS# 7732-18-5:
Personal Protective Equipment
Eyes:
Not available.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to minimize
contact with skin.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: HNaO
Molecular Weight: 40
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable.
Conditions to Avoid:
Not available.
Incompatibilities with Other Materials:
Not available.
Hazardous Decomposition Products:
Not available.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1310-73-2: WB4900000
CAS# 7732-18-5: ZC0110000
LD50/LC50:
CAS# 1310-73-2: Draize test, rabbit, eye: 400 ug Mild; Draize test,
rabbit, eye: 1% Severe; Draize test, rabbit, eye: 50 ug/24H Severe;
Draize test, rabbit, eye: 1 mg/24H Severe; Draize test, rabbit,
skin: 500 mg/24H Severe.
CAS# 7732-18-5: Oral, rat: LD50 = >90 mL/kg.
Carcinogenicity:
Sodium hydroxide -
Not listed by ACGIH, IARC, or NTP.
Water -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 1310-73-2: 1000 lb final RQ; 454 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1310-73-2: 1
CAS# 7732-18-5: No information available.
Canada
CAS# 1310-73-2 is listed on Canada's DSL List.
CAS# 7732-18-5 is listed on Canada's DSL List.
CAS# 1310-73-2 is listed on Canada's Ingredient Disclosure List.
CAS# 7732-18-5 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 1310-73-2 is listed on the TSCA inventory.
CAS# 7732-18-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
R 35 Causes severe burns.
MSDS Creation Date: 6/24/2003 Revision #0 Date: Original.
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
1,3-Benzodioxol-5-ylmethyl isothiocyanate, 95%+
| 4430-47-1 |
|
3-Chloro-4-fluorobenzene-1-carbothioamide, tech
| 130560-97-3 |
|
2-(1-Methylhydrazino)-4-(trifluoromethyl)pyridine, 97%
| 208720-09-6 |
|
2-(Methylsulfanyl)-5,6-dihydro-4H-1,3-thiazine, 97%
| 58842-19-6 |
|
4-Chlorophenyl isothiocyanate, 97%
| 2131-55-7 |
|
1-[2,6-Dichloro-4-(trifluoromethyl)phenyl]hydrazine, 95+%
| 86398-94-9 |
|
2-Methylbenzene-1-sulfonamide, 97%
| 88-19-7 |
|
Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate, 97%
| 637-07-0 |
|
Silicagel, functionalized, pyridinium chlorochromate
| 00-01-1 |
|
Silicagel, functionalized, (cyclohexylcarbodiimido)propyl
| 0-01-1 |
|
Silicagel, functionalized,(trimethylammonium)propyl cyanoborohydride
| 0-01-1 |
|
(s)-(+)-Octen-3-ol
| 24587-53-9 |
|
Triisopropyl phosphite
| 116-17-6 |
|
Methyl 2-methyl-3-furyl disulfide, 98%
| 65505-17-1 |
|
6-Chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl chloride, 95+%
| 150020-64-7 |
|
2,4-Dimethoxybenzenesulfonyl chloride, 97%
| 63624-28-2 |
|
4-(Trimethylsilyl)morpholine
| 13368-42-8 |
|
Methyl 3-(4-hydroxyphenyl)propionate
| 5597-50-2 |
|
Bis(tributylstannyl)acetylene
| 994-71-8 |
|
3,6-Difluorophthalic anhydride
| 652-40-4 |
|
2,4-Dimethoxybenzoyl chloride
| 39828-35-8 |
|
Tributylphenyltin
| 960-16-7 |
|
4-Mercaptophenol
| 637-89-8 |
|
Chlorodimethyloctadecylsilane, 90%
| 18643-08-8 |
|
Triisopropylsilane, 95%
| 6485-79-6 |
|
6-Chloro-3-indoxyl butyrate
| 159954-34-4 |
|
2-Cyanobenzaldehyde
| 7468-67-9 |
|
(Methoxycarbonylsulfamoyl)triethylammonium hydroxide, inner salt
| 29684-56-8 |
|
(S)-(-)-1-Phenylethylamine, produced by BASF AG
| 2627-86-3 |
|
(R)-(+)-1-Phenylethylamine, produced by BASF AG
| 3886-69-9 |
|
tert-Butyl 2,2,2-trichloroacetimidate
| 98946-18-0 |
|
2,4-Dimethoxybenzylamine
| 20781-20-8 |
|
N-Ethylisopropylamine
| 19961-27-4 |
|
Pentacosane
| 629-99-2 |
|
BOC-L-Isoglutamine
| 18800-74-3 |
|
Sodium hydroxide, 0.05 N solution
| 1310-73-2 |
|
2,4,5-Trichlorophenol
| 95-95-4 |
|
2,6-Di-tert-butyl-4-methylpyridine
| 38222-83-2 |
|
3,5-Dimethyl-1-hexyn-3-ol
| 107-54-0 |
|
2,4,7,9-Tetramethyl-5-decyne-4,7-diol, mix ture of (delta1) and meso,
| 126-86-3 |
|
2,2-Dimethyl-4-pentenal, stabilized
| 123-31-9 |
|
D-(-)-Erythrose, 65% aqueous solution
| 583-50-6 |
|
DL-3-Hydroxy-4-methoxymandelic acid, 95%
| 3695-24-7 |
|
(S)-4-tert-Butyldimethylsilyloxy-2-cyclopenten-1-one, 90%
| 61305-36-0 |
|
N-Carbobenzyloxy-L-Proline, 99%
| 1148-11-4 |
|
(R)-(+)-Citronellal, 90%
| 2385-77-5 |
|
5,7-Dichloro-8-quinaldinol, 98%
| 72-80-0 |
|
Bromodiphenylmethane, 90%
| 776-74-9 |
|
Cyclohexylmethyl bromide, 96%
| 2550-36-9 |
|
NADPH tetrasodium salt, 95%
| 2646-71-1 |
|
|